GHU St Anne Psychiatrie et Neurosciences
- Address
- 1 rue Cabanis, 75014 Paris, France
Psychiatry & Mental Health
The Department of Neurology at GHU St Anne Psychiatrie et Neurosciences conducts research aimed at improving outcomes for patients with severe mood disorders, especially those who have not responded to standard treatments.
- Psilocybin‑enhanced psychotherapy
- Combination therapy with trazodone
- Proof‑of‑concept studies in depression
- Neurobiological markers of treatment response
These investigations seek to test innovative therapeutic strategies that could provide rapid relief of depressive symptoms and deepen understanding of the brain mechanisms underlying treatment resistance.
Stroke & Vascular Neurology
In the field of cerebrovascular disease, the site evaluates acute interventions for patients who have taken direct oral anticoagulants and experience an ischemic stroke.
- Intravenous thrombolysis with alteplase or tenecteplase
- Functional outcome measured by the modified Rankin Scale
- Safety profiling of thrombolysis in anticoagulated patients
- Optimization of emergency stroke pathways
The purpose of these studies is to determine whether a tailored IV thrombolysis strategy can improve recovery and reduce long‑term disability compared with standard care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in GHU St Anne Psychiatrie et Neurosciences
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Intravenous Thrombolysis with Alteplase or Tenecteplase in Acute Ischemic Stroke Patients on Direct Oral Anticoagulants | Insel Gruppe AG | Phase III | Recruiting | Aug 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alteplase | 1 | Unknown | 2025-08-04 | 2025-08-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.